We are live on ! Find out more
DTIL icon

Precision BioSciences

52 hedge funds and large institutions have $18.6M invested in Precision BioSciences in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

8% more funds holding

Funds holding: 4852 (+4)

3.89% more ownership

Funds ownership: 36.13%40.02% (+3.9%)

3% more capital invested

Capital invested by funds: $18.1M → $18.6M (+$575K)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
11
Increased
14
Reduced
8
Closed
7
Calls
Puts
Net Calls
Net Calls Change

DTIL Hedge Fund Activity: Q2 2025 in Review

52 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2025, worth a combined $18.6M — up 3.2% from $18.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new DTIL positions and 7 closed out — a net gain of 4 holders — while 14 added to existing stakes and 8 trimmed.

The largest buyer was Bleichroeder LP, adding an estimated $5.24M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $905K sold.

  • 52 institutional investors held Precision BioSciences (DTIL) as of Q2 2025, up from 48 in Q1 2025.
  • Funds reported $18.6M of Precision BioSciences stock for Q2 2025, up 3.2% quarter-over-quarter.
  • 11 funds opened new Precision BioSciences positions in Q2 2025 and 7 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q2 2025 was Bleichroeder LP, an estimated $5.24M added.
  • The largest Precision BioSciences seller in Q2 2025 was Balyasny Asset Management, an estimated $905K sold.

Based on aggregated 13F filings for Q2 2025.